Timothy J. Guzi,David A. Parry,Marc A. Labroli,Michael D. Dwyer,Kamil Paruch
申请号：
US12744021
公开号：
US08603998B2
申请日:
2008.11.05
申请国别(地区):
US
年份:
2013
代理人:
摘要：
In its many embodiments, the present invention provides a novel class of pyrimidine analogs of formula (V) as targeted mechanism-based modulators of cell cycle checkpoints. Cancers and/or malignancies can be treated by administration of a cell cycle checkpoint modulator of the invention. Also discussed are suitable combinations of the cell cycle checkpoint modulator with a checkpoint kinase inhibitor to produce synergistic apoptosis in cancer cells. The invention includes methods of treating cancers by administering the combination of the cell cycle checkpoint modulator and the checkpoint kinase inhibitor, pharmaceutical compositions comprising the activator as well as the combination and pharmaceutical kits.
